US equities |
MU $1,045.56 ▲+0.00% INTC $112.50 ▲+0.00% NVDA $239.24 ▲+0.00% SNDK $1,660.46 ▲+0.00% SPCX $171.92 ▲+0.00% MRVL $287.01 ▲+0.00% AMD $649.42 ▲+0.00% MSTR $164.55 ▲+0.00%
FinancialContent

Articles published by Oyster Point Pharma, Inc.

News headline image
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
News headline image
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST VTRS
News headline image
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST VTRS
News headline image
Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
News headline image
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
News headline image
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
News headline image
Oyster Point Pharma Announces Expanded Patient Access to TYRVAYA®
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST